Diversity & Clinical Trials: Access & Trust
Presented by Johnson & Johnson Innovation – JLABS and Newlab—a new limited event series focused on the topic of diversity, equity, and inclusion (DEI) in healthcare and clinical trials.
Event Recap
Join us on June 23rd at 12:00PM ET for part one of Diversity & Clinical Trials, Access & Trust. Our panel of speakers will investigate how recurring challenges in patient access to clinical trials affect study design, recruitment & retention, and diversity in data sets. What efforts should trial stakeholders explore to build trust and encourage buy-in into the trial process amongst diverse communities that are continually underrepresented?
Moderated by:
- Kimberly Tableman — CEO, Medicine X
Featuring special guests:
- Ramona Burress — Associate Director, Diversity & Inclusion in Clinical Trials, The Janssen Pharmaceutical Companies of Johnson & Johnson
- Eric Roberts — Vice President, Trial Diversity & Inclusion, Real Chemistry
- Sophia Goodison —Director, Oncology, Safety Evaluation and Risk Management (SERM) Scientist, GSK